OncoVITA news

Dedicated to the research of new immunotherapeutic vaccines in oncology and prophylactic vaccines for contagious diseases, the aim of the joint Institut Pasteur – Oncovita laboratory is to design and develop  vaccine candidates through to proof of concept in humans.

Oncovita and the Institut Pasteur have already been working together for several years on the construction and development of new vaccines based on Measovir^R technology, based on the measles vacc